CAT vs ERNA · P/E 48, rev $20.54B vs P/E 0.0, rev $582.0K
Caterpillar Inc (CAT) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the CAT and ERNA stock pages for the full models.
Not investment advice.